People: Chugai Pharmaceutical Co Ltd (4519.T)
2,410JPY
21 May 2013
¥-12 (-0.50%)
¥2,422
¥2,422
¥2,437
¥2,395
517,100
1,615,785
¥2,550
¥1,379
Nakamura, Naotaka
Brief Biography
Mr. Naotaka Nakamura has been serving as Senior Managing Executive Officer in CHUGAI PHARMACEUTICAL CO., LTD. since March 25, 2010. He joined the Company in April 1976, and previously served as Chief Director of Sales, Director of Sales, Director of Medical Drug Promotion, Director of 4th Learning, Executive Officer, Chief Director of Learning, Deputy Chief Director of Sales, Manager of Oncology Unit, Director of Overseas Sales Promotion and Director in the Company.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Osamu Nagayama |
-- |
Tatsuro Kosaka |
-- |
Motoo Ueno |
-- |
Yoshio Itaya |
-- |
Tatsumi Yamazaki |
-- |
Naotaka Nakamura |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
